Could machine learning present a paradigm shift in drug discovery?

Angharad Baldwin catches up with Dr Raymond Barlow, CEO at e-therapeutics, about what network-driven drug discovery can offer the pharmaceutical industry in its pursuit of new medicines

picture of Dr Raymond Barlow, CEO, e-therapeutics

Breaking News

BioLingus partnership boosts WuXi STA’s solid dose potential

The collaboration will use BioLingus' technology to focus on sublingual and buccal drug delivery

Qiagen enters agreement with precision diagnostics company

The German company has received an exclusive license to use Ares Genetics’s database and toolbox, to develop ...

Paris to host inaugural HealthTech Investor Day

In June, under the patronage of French President, Emmanuel Macron, France Biotech will play host to a gathering of ...

Molecule: Pooling the pharma industry's resources

The new software platform from Linum Labs has been designed to crowdsource funding and research, in an effort to ...

Helsinn invests €1 million in Gain Therapeutics

Swiss company will use the funding to address lysosomal storage disorders, CNS indications and additional diseases

Nemus and Pharmaceuticals International look to THC

Companies have agreed to develop a sterile eye drop dosage formulation, based on a cannabinoid, for Glaucoma

Is the production of biologic drugs ready for an overhaul?

Is the industry ready for a new manufacturing model? Mark Emalfarb, President and CEO of Dyadic International, thinks ...

Emergex secures R&D facility in Oxfordshire

English biotech company now has overall internal control of all its vaccine development programmes

Nestlé tackles phenylketonuria with Codexis enzyme

Codexis announces that Nestlé Health Science has exercised its option to obtain an exclusive license for the global ...

qNMR: top tips for optimised sample prep

NMR spectra provide various types of information, usually focused on the identification of the compounds contained in a ...

Leaders of transformation

Haig Armaghanian, founder and CEO of Haig Barrett, explores how synthetic biology pioneers are revolutionising ...

Why intellectual property is vital to the success of R&D

Life changing medicinal breakthroughs and cutting-edge surgical technology just would not exist without vital research ...

Lonza allies with Emerald Health on synthetic cannabinoid therapy

The Swiss CDMO has signed a manufacturing agreement to produce the active ingredient of a cannabinoid therapy for ...

Fujitsu joins forces with university team to create diabetes AI

Sapporo Medical University, Fujitsu, and Fujitsu Hokuriku Systems have announced a collaboration to create model- ...